---
title: 'Manufacturing Daily Summary: What Happened on November 11, 2026'
headline: Packaging criteria and polysorbate testing in focus
description: A trade publication outlined how to assess packaging providers and listed
  a webinar on measuring two common biopharma stabilizers.
url: https://thebench.bio/news/manufacturing/2026-11-11
topic: manufacturing
date: '2026-11-11'
covers:
- '2026-11-11'
date_published: '2026-11-12T00:03:07Z'
date_modified: '2026-11-12T00:03:07Z'
tags:
- Industry
sources: 2
publisher: TheBench.Bio
---

# Manufacturing Daily Summary: What Happened on November 11, 2026

**Packaging criteria and polysorbate testing in focus**

A trade publication outlined how to assess packaging providers and listed a webinar on measuring two common biopharma stabilizers.

## Today in brief

BioPharm International outlined criteria for choosing a pharmaceutical packaging provider, including compliance, protective design, security and global sourcing. [1] It also listed a December 2 webinar on liquid chromatography methods for measuring polysorbates in biopharmaceutical materials and drug products. [2]

## Also worth knowing

- The packaging article argues that compromised shipments can delay regulatory timelines or put patients at risk, and recommends assessing providers beyond price and speed. [1]
- Polysorbates 20 and 80 stabilize protein-based drugs, but their varied composition, weak ultraviolet response and susceptibility to degradation complicate measurement. [2]

## Sources

1. [cGMP-Compliant Pharmaceutical Packaging Companies: Capabilities to Evaluate for Product Integrity and Global Supply](<https://www.biopharminternational.com/view/cgmp-compliant-pharmaceutical-packaging-companies-capabilities-to-evaluate-for-product-integrity-and-global-supply>), BioPharm International, 2026-11-11
2. [Excipients in Biopharma: Polysorbate 20 and 80 Analysis](<https://www.biopharminternational.com/view/excipients-in-biopharma-polysorbate-20-and-80-analysis>), BioPharm International, 2026-11-11

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.biopharminternational.com/view/cgmp-compliant-pharmaceutical-packaging-companies-capabilities-to-evaluate-for-product-integrity-and-global-supply>
[2]: <https://www.biopharminternational.com/view/excipients-in-biopharma-polysorbate-20-and-80-analysis>
